There were 501 press releases posted in the last 24 hours and 399,837 in the last 365 days.

Synthetic Biology Market Report 2021-2031: Visiongain Research Inc.

Visiongain has published a new report on Synthetic Biology Market Report 2021-2031: Forecasts By Product Type (Oligonucleotides, Enzymes, Cloning Technology Kits, Synthetic Cells, Synthetic Genes, Synthetic DNA, Synthetic Clones, Chassis Organisms, Xeno-Nucleic Acids, and Others), By Technology (Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Cloning, Site-Directed Mutagenesis, Measurement & Modeling, Microfluidics, Nanotechnology, and Others), By Application (Medical Applications, Pharmaceuticals, Industrial Applications, Food & Agriculture, Environmental Applications, and Others), By Patient Demographics (Adults, Geriatric, and Pediatric), By End User (Medical Industries, Industrial Industries, Food & Agriculture Industries, Environmental Industries, and Others), By Distribution Channel (Direct Tender, and Retail Sales) PLUS Profiles of Leading Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

COVID-19 Impact on Synthetic Biology
COVID-19 impact through different recovery models such as V-shaped, U-shaped, W-shaped, and L-shaped; has been taken into consideration while estimating and forecasting the Synthetic Biology. Different recovery scenarios are also included in the report for all the segments and regions/nation. The recovery scenarios based on which market has been forecasted and analyzed herein the report are mentioned below.

Download Exclusive Sample of Report @

Market Drivers

Rising Funding and Growing Initiatives in Synthetic Biology
There is a very rapid increase in demand for synthetic biology around the world. Recently, the market has reported a sudden rise in the demand of synthetic biology along with increasing regulatory approvals, funding, and growing initiatives. Various manufacturers have increased their funding for synthetic biology and on the other hand many manufacturers have launched their product portfolios in synthetic biology which have helped to fulfill demand and work as drivers for the market.

Increasing Geriatric Population around the World
an increasing in geriatric population is suffering from chronic and non-chronic disease. All regions are facing a huge increase in the number of geriatric populations. For instance: According to the United Nations, Department of Economic and Social Affairs, the Population Division geriatric population (persons aged 65 or over) was 702.9 million in 2019. Rapid increase in the number of the geriatric population around the globe is also increasing demand for synthetic drugs and vaccines around the world. Due to this increasing geriatric population around the world is working as a market driver for synthetic biology.

Market Opportunities

Increasing Research in Synthetic Drugs and Vaccines
Researchers and pharmaceutical manufacturers from all over the world are increasing their focus on research and development for synthetic drugs and vaccines and are taking required steps to create synthetic drugs and vaccines. Researcher and pharmaceutical manufacturing in developing nations are undergoing tumultuous research and development from the last few years and each change is only for synthetic drugs and vaccines. Increasing focus on synthetic drugs and vaccines is expected to increase the number of synthetic drugs and vaccines which are expected to create new opportunities for synthetic biology. Due to this reason the factor is creating various opportunities for synthetic biology.

Get Detailed TOC @

How the Synthetic Biology Market report helps you
In summary, our 300+ page report provides you with the following knowledge:

  • Revenue forecasts to 2031 for Synthetic Biology Market, with forecasts for Get our report today Synthetic Biology Market Forecast 2021-2031: By Product Type, Technology, Application, Patient Demographics, By End User, Distribution Channel and Leading Regional/ Country market analysis each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Synthetic Biology market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Synthetic Biology Market.

Competitive Landscape

Top companies (Shire plc (Thermo Fisher Scientific, Inc., Merck Kgaa, and Agilent Technologies, Inc.) constitute more than XX% share of the global Synthetic Biology. Other companies profiled in the report include: Novozymes A/S, Ginkgo Bioworks, Amyris, Inc., Intrexon Corporation, Genscript Biotech Corporation, Twist Bioscience, Synthetic Genomics, Inc. (SGI), Codexis, Inc., Synthego Corporation, Creative Enzymes, Eurofins Scientific, Cyrus Biotechnology, Inc. Some of the key developments are listed below:

In 2019, Agilent Technologies acquired BioTek Instruments for $1.17 billion. BioTek is exploring designing, manufacturing, and marketing of instruments for the life science industry, including microplate readers, cell imaging systems, dispensers, washers, automated incubators, and stackers. The acquisition will help the company to expand its synthetic biology portfolio.

In 2018, Precigen, Inc., has built a new manufacturing facility for gene therapy manufacturing. Precigen, Inc., is a clinical stage biopharmaceutical company which is specialized in the innovative development of gene and cellular therapies. The new facility will help the company to increase its market presence in the synthetic biology market.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

To access the data contained in this document please email

Information found nowhere else
with our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Synthetic Biology Market and leading companies. You will find data, trends, and predictions.

Find more research reports on the Pharma Diagnostics Sectorplease click on the following links:

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help:

About Visiongain

Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports means that you can have a bespoke piece of market intelligence customized to your very own business needs. 


Sara Peerun
Commercial Director
Visiongain Inc.
Tel: + 44 207 549 9987
USA Tel: 00 1 718 682 4567
EU Tel: 00 353 1 695 0006
Follow Us: LinkedIn | Twitter


SOURCE Visiongain Limited.

Primary Logo